W Sun, J Li, L Zhou, J Han, R Liu, H Zhang, T Ning… - Theranostics, 2020 - ncbi.nlm.nih.gov
Oxaliplatin (OXA) resistance is the major obstacle to the anticancer effects of chemotherapy
in colorectal cancer (CRC) patients. MicroRNAs (miRNAs) play an important role in the …